Boston Scientific (NYSE: BSX)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Boston Scientific Returns vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Boston Scientific Company Info
The Company develops, manufactures & markets medical devices that are used in interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology & neuromodulation.
News & Analysis
The pandemic is only a temporary setback for this diversified global manufacturer of medical devices.
New products mean solid revenue may be ahead for these companies.
Newly released products will drive revenue growth, but will they benefit shareholders?
High demand for a single product can't sustain an industry.
The pandemic has slowed sales for the two medical device companies. Which stock is ready to rise when medical procedures return?
But a sharp decline in medical procedures caused a drop in first-quarter profits.
The company's Coventor will retail for under $1,000.
The coronavirus outbreak meant the postponement of medical procedures, weighing on Boston Scientific’s revenue.
Motley Fool Returns
Market-beating stocks from our award-winning analyst team.
Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 02/02/2023.
Discounted offers are only available to new members. Stock Advisor list price is $199 per year.
Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.
Valuation
Earnings Transcripts
BSX earnings call for the period ending June 30, 2022.
BSX earnings call for the period ending March 31, 2022.
BSX earnings call for the period ending December 31, 2021.
BSX earnings call for the period ending September 30, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.